The FDA’s decision on Novavax’s COVID-19 vaccine could come in weeks
May 26, 2022 at 11:15 AM EDT
The company's protein-based shot has been authorized or approved in several other countries, including the U.K. and Singapore.
Photography by Christophe Tomatis